U.S. regulators approve Wegovy pill for weight lossU.S. regulators approve Wegovy pill for weight loss
U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. (Image credit: Jacquelyn Martin) U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to Read More
Ozempic Meals? Restaurants shrink portions to match bite-sized hungerOzempic Meals? Restaurants shrink portions to match bite-sized hunger
A self-described foodie, social butterfly and New Yorker for 20 years, Lina Axmacher has long loved exploring the city’s famed restaurant culture. A self-described foodie, social butterfly and New Yorker for 20 years, Lina Axmacher has long loved exploring the city’s famed restaurant culture.
Novo Nordisk says US approves first GLP-1 pill for weight lossNovo Nordisk says US approves first GLP-1 pill for weight loss
Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular GLP-1 anti-obesity drug Wegovy to be administered in pill form for weight loss. Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular GLP-1 anti-obesity drug Wegovy to be Read More
US regulator approves pill form of Wegovy weight-loss drugUS regulator approves pill form of Wegovy weight-loss drug
Wegovy becomes first pill of its kind to be approved, shifting weight-loss drugs beyond injections. Wegovy becomes first pill of its kind to be approved, shifting weight-loss drugs beyond injections.
US regulators approve Wegovy pill, first oral medication to treat obesityUS regulators approve Wegovy pill, first oral medication to treat obesity
Food and Drug Administration’s approval hands drugmaker Novo Nordisk an edge in the race to market an obesity pill US regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The US Food and Drug Administration’s approval handed drugmaker Novo Read More
FDA approves Wegovy pill for weight lossFDA approves Wegovy pill for weight loss
The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy. The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy.
Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist DiscontinuationGestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation
This cohort study examines gestational weight gain and pregnancy outcomes after glucagon-like peptide-1 (GLP-1) receptor agonist discontinuation. This cohort study examines gestational weight gain and pregnancy outcomes after glucagon-like peptide-1 (GLP-1) receptor agonist discontinuation.
Increasing Postpartum Use of GLP-1 Receptor AgonistsIncreasing Postpartum Use of GLP-1 Receptor Agonists
This study uses data from the Danish Medical Birth Register to examine postpartum use of glucagon-like peptide 1 receptor agonists. This study uses data from the Danish Medical Birth Register to examine postpartum use of glucagon-like peptide 1 receptor agonists.
Guiding Obstetric Care and Treatment Decisions for Women With Prior GLP-1 Receptor Agonist UseGuiding Obstetric Care and Treatment Decisions for Women With Prior GLP-1 Receptor Agonist Use
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as liraglutide and semaglutide, have revolutionized treatment of obesity. Obesity and obesity-related comorbidities increase the risks of adverse outcomes such as miscarriage, congenital malformations, preterm birth, gestational diabetes, and preeclampsia, which can have significant long-term consequences for mother and infant. By enabling women to begin pregnancy at a lower Read More
Adjuvant Chemotherapy for HR-Positive ERBB2- Negative Breast CancerAdjuvant Chemotherapy for HR-Positive ERBB2- Negative Breast Cancer
Oncology